6OE4 image
Deposition Date 2019-03-27
Release Date 2019-04-17
Last Version Date 2024-11-20
Entry Detail
PDB ID:
6OE4
Title:
Prefusion RSV F monomer bound by neutralizing antibody CR9501
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Fusion glycoprotein F0
Gene (Uniprot):F
Mutagens:S155C, S290C
Chain IDs:A, B (auth: D)
Chain Length:521
Number of Molecules:2
Biological Source:Human respiratory syncytial virus A (strain A2)
Polymer Type:polypeptide(L)
Molecule:CR9501 Fab Heavy Chain
Chain IDs:D (auth: B), E
Chain Length:230
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:CR9501 Fab Light Chain
Chain IDs:C, F
Chain Length:214
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Transient opening of trimeric prefusion RSV F proteins.
Nat Commun 10 2105 2105 (2019)
PMID: 31068578 DOI: 10.1038/s41467-019-09807-5

Abstact

The respiratory syncytial virus (RSV) F glycoprotein is a class I fusion protein that mediates viral entry and is a major target of neutralizing antibodies. Structures of prefusion forms of RSV F, as well as other class I fusion proteins, have revealed compact trimeric arrangements, yet whether these trimeric forms can transiently open remains unknown. Here, we perform structural and biochemical studies on a recently isolated antibody, CR9501, and demonstrate that it enhances the opening of prefusion-stabilized RSV F trimers. The 3.3 Å crystal structure of monomeric RSV F bound to CR9501, combined with analysis of over 25 previously determined RSV F structures, reveals a breathing motion of the prefusion conformation. We also demonstrate that full-length RSV F trimers transiently open and dissociate on the cell surface. Collectively, these findings have implications for the function of class I fusion proteins, as well as antibody prophylaxis and vaccine development for RSV.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback